Glaxosmithkline Holdings (americas) Inc. Contracts with Department of Health and Human Services
Relationship Overview
Total Contract Value: $2,869,349,976
Contract Count: 9
Average Contract Size: $318.8M
Sole Source Rate: 0%
Small Business Rate: 0%
Spending by Sector
- Other: $2.9B (9 contracts)
Contracts
- VACCINE FOR CHILDREN 2010 — $465.2M
- 200-2007-20307 - GLAXOSMITHKLINE'S PEDIATRIC VACCINE CONTRACT — $458.6M
- VACCINE FOR CHILDREN 2011 — $427.7M
- VACCINE FOR CHILDREN 2008 — $427.0M
- VFC 2006 — $385.0M
- 00HCVGBC-2009-68751 - GSK VFC PEDIATRIC VACCINE CONTRACT — $366.0M
- RESEARCH AND DEVELOPMENT FACILITIES — $136.8M
- ANTIVIRAL PURCHASE FOR THE STRATEGIC NATIONAL STOCKPILE (RELENZA) — $130.3M
- DRUGS AND BIOLOGICALS — $72.8M
Frequently Asked Questions
How many contracts does Glaxosmithkline Holdings (americas) Inc. have with Department of Health and Human Services?
Glaxosmithkline Holdings (americas) Inc. has 9 contracts with Department of Health and Human Services worth a combined $2.9B.
What is the average contract size between Glaxosmithkline Holdings (americas) Inc. and Department of Health and Human Services?
The average contract size is $318.8M.
What percentage of Glaxosmithkline Holdings (americas) Inc.'s contracts with Department of Health and Human Services are sole-source?
0% of the contracts are sole-source awards.